# The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis

> **NCT00573157** · PHASE2,PHASE3 · TERMINATED · sponsor: **EMD Serono** · enrollment: 6 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Atacicept
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Placebo
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT00573157
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The study was terminated due to unanticipated safety issues
- **Last updated:** 2016-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573157, "The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00573157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*